Skip to main content
HR 3781 109th Congress House Health AIDS (Disease) Child health Clinical trials Commerce Communicable diseases Competition Congress Congressional reporting requirements Contracts Corporation taxes Developing countries Development credit institutions Dispute settlement Drug approvals Drug industry Drugs Economics and Public Finance Families Foreign Trade and International Finance

Vaccines for the New Millennium Act of 2005

Introduced: September 14, 2005 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 109th Congress ended
It never became law before the 109th Congress (2005–2006) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 17, 2005
Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology.
Oct 7, 2005
Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
Sep 14, 2005
Referred to the Committee on Ways and Means, and in addition to the Committees on International Relations, Energy and Commerce, Small Business, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 14, 2005
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Vaccines for the New Millennium Act of 2005 - Directs the President to establish a strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis, which shall: (1) expand public-private partnerships; (2) create economic incentives for such vaccines' research, development, and manufacturing; (3) include the negotiation of advanced market commitments; (4) address related intellectual property and regulatory approval issues; (5) maximize U.S. capabilities to support clinical trials in developing countries; (6) expand the purchase and delivery of existing vaccines; and (7) address the challenges of advance delivery of vaccines in developing countries.

Directs the Secretary of the Treasury to: (1) enter into negotiations with the World Bank, the International Development Association, Global Alliance for Vaccines and Immunizations, and other interested parties to establish advanced market commitments to purchase such vaccines and microbicides; and (2) establish in the Treasury the Lifesaving Vaccine Purchase Fund.

Amends the Internal Revenue Code to establish business credits for: (1) vaccine research related to HIV/AIDS, malaria, tuberculosis, or certain infectious diseases afflicting developing countries; and (2) certain sales of lifesaving vaccines to nonprofit organizations, or to foreign governments or instrumentalities for distribution in developing countries.

Amends the Small Business Act to: (1) direct the Small Business Administration (SBA) to establish a four-year pilot program to encourage the development of such vaccines and microbicides, including program outreach activities; and (2) provide Small Business Innovation Research Program (SBIR) and Small Business Technology Transfer Program (STTR) funding for such vaccines and microbicides.

What's happening now October 17, 2005

Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology.

 Related & companion bills 1
  • S 1698 Identical bill Vaccines for the New Millennium Act of 2005
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 7
 Cosponsors 3
All 3 Democratic 3
D
Davis, Danny K.
Illinois · Oct 7, 2005
 D
McGovern, James P.
Massachusetts · Oct 7, 2005
 D
Sherman, Brad
California · Oct 7, 2005
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3781: Vaccines for the New Millennium Act of 2005. 109th Congress. Open America. https://openamerica.io/bill/109-HR-3781/
MLA
"H.R. 3781: Vaccines for the New Millennium Act of 2005." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-3781/.
Bluebook (legal)
H.R. 3781, 109th Cong. (2026), https://openamerica.io/bill/109-HR-3781/.
Markdown link
[H.R. 3781: Vaccines for the New Millennium Act of 2005](https://openamerica.io/bill/109-HR-3781/)
Report a problem